Clinical trial
EH301 for the Treatment of Amyotrophic Lateral Sclerosis: a Placebo-Controlled Study
NCT03489200 is registered in ClinicalTrials.gov with Elysium Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EH301 for the Treatment of Amyotrophic Lateral Sclerosis: a Placebo-Controlled Study
- Lead sponsor
- Elysium Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2017
- Completion date
- June 30, 2017
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.